Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Hematology | Oncology
T-Cell Lymphoma Clinical Trials
A listing of T-Cell Lymphoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.
Georgia
Augusta : Georgia Health Sciences University Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Michigan
Novi : Detroit Clinical Research Center, PC Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
New York
New York : Memorial Sloan-Kettering Cancer Center Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
New York : New York Presbyterian Hospital Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Tennessee
Nashville : Tennessee Oncology, PLLC
Phase Ib Study of IPI-145 in Combination With Bendamustine, Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
Australia
Adelaide : Royal Adelaide Hospital Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Fitzroy : Saint Vincent's Hospital Melbourne Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Frankston : Frankston Hospital Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Hobart : Royal Hobart Hospital Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Malvern : Cabrini Health Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Canada
Calgary : Tom Baker Cancer Centre
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
Edmonton : Cross Cancer Institute
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
Halifax, : Queen Elizabeth II, Health Services Centre
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
Ottawa : Ottawa Hospital General Campus
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
Toronto : Sunnybrook Health Science Centre Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
View More »
Winnipeg : Cancer Care Manitoba
A Phase II Clinical Trial of Lenalidomide for T-cell Non-Hodgkin's Lymphoma
Israel
Tel Hashomer : Chaim Sheba Medical Center Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
New Zealand
Milford : North Shore Hospital Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Poland
Gdansk : Dept of Hematology and Transplantology Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Kraków : Małopolskie Centrum Medyczne Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Warszawa : Klinika Nowotworów Ukladu Chlonnego Centrum Onkologii Instytut Marii Sklodowskiej-Curie Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Puerto Rico
San Juan : Auxilio Mutuo Cancer Center Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
United Kingdom
Devon : Derriford Hospital Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Glasgow : NHS Greater Glasgow and Clyde Western Infirmary Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
Middlesex : Mount Vernon Cancer Centre Updated
Study of Pralatrexate Versus Observation Following CHOP-based Chemotherapy in Previously Undiagnosed Peripheral T-cell Lymphoma Patients
